{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:14:24Z","timestamp":1790644464376,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>The blastoid (B) and pleomorphic (P) variants of mantle cell lymphoma (MCL) are associated with aggressive clinical behavior. In this study, we collected 102 cases of B-MCL and P-MCL from untreated patients. We reviewed clinical data, analyzed morphologic features using an image analysis tool (ImageJ) and we assessed mutational and gene expression profiles. The chromatin pattern of lymphoma cells was assessed quantitatively by the pixel value. Cases of B-MCL showed a greater median pixel value with lower variation compared with P-MCL, indicating a homogeneously euchromatin-rich pattern in B-MCL. In addition, the Feret diameter of the nuclei was significantly smaller (median 6.92 vs. 8.49\u00a0\u00b5m per nucleus, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and had a lesser degree of variation in B-MCL compared with P-MCL, indicating that B-MCL cells have smaller cells with a more monomorphic appearance. B-MCL showed a significantly higher median Ki-67 proliferation rate (60% vs. 40%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.003), and affected patients had poorer overall survival compared with those with P-MCL (median overall survival: 3.1 vs. 8.8\u00a0y, respectively, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.038). <jats:italic toggle=\"yes\">NOTCH1<\/jats:italic> mutation was significantly more frequent in B-MCL compared with P-MCL (33% and 0%, respectively, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.004). Gene expression profiling showed 14 genes overexpressed in B-MCL cases and gene set enrichment assay for the overexpressed genes showed significant enrichment in the cell cycle and mitotic transition pathways. We also report a subset of MCL cases that has blastoid chromatin but a higher degree of pleomorphism in nuclear size and shape, designated here as hybrid MCL. Hybrid MCL cases had a similar Ki-67 proliferation rate, mutation profile, and clinical outcome to B-MCL and distinct from P-MCL. In summary, these data suggest biological differences between B-MCL and P-MCL cases justifying their separate designation when possible.<\/jats:p>","DOI":"10.1097\/pas.0000000000002068","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T12:00:15Z","timestamp":1686225615000},"page":"849-858","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features"],"prefix":"10.1097","volume":"47","author":[{"given":"Mahsa","family":"Khanlari","sequence":"first","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Mo","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sakhdari","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Pathology, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetesh","family":"Jain","sequence":"additional","affiliation":[{"name":"Lymphoma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[{"name":"Lymphoma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-7880","authenticated-orcid":false,"given":"Chi Young","family":"Ok","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"R1-20250608","first-page":"406","article-title":"Classification of non-Hodgkin\u2019s lymphomas","volume":"304","author":"Gerard-Marchant","year":"1974","journal-title":"Lancet"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0308-2261(74)80005-6","article-title":"Histopathology of malignant lymphomas","volume":"3","author":"Berard","year":"1974","journal-title":"Clin Haematol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/1097-0142(19820401)49:7<1429::AID-CNCR2820490720>3.0.CO;2-5","article-title":"Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma","volume":"49","author":"Weisenburger","year":"1982","journal-title":"Cancer"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V76.7.1387.1387","article-title":"Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus","volume":"76","author":"Williams","year":"1990","journal-title":"Blood"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V76.10.2086.2086","article-title":"Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation","volume":"76","author":"Medeiros","year":"1990","journal-title":"Blood"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2559.1995.tb00615.x","article-title":"Mantle cell lymphoma: a clinicopathological study of 55 cases","volume":"26","author":"Pittaluga","year":"1995","journal-title":"Histopathology"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones","volume":"89","author":"Ott","year":"1997","journal-title":"Blood"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2559.1994.tb00533.x","article-title":"The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices","volume":"24","author":"Ott","year":"1994","journal-title":"Histopathology"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1182\/blood-2017-08-737502","article-title":"Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!","volume":"132","author":"Dreyling","year":"2018","journal-title":"Blood"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1349-7006.2009.01433.x","article-title":"Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67","volume":"101","author":"Kimura","year":"2010","journal-title":"Cancer Sci"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann","year":"2005","journal-title":"Br J Haematol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41379-021-00885-9","article-title":"EZH2 expression is associated with inferior overall survival in mantle cell lymphoma","volume":"34","author":"Martinez-Baquero","year":"2021","journal-title":"Mod Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","article-title":"Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification","volume":"33","author":"Arganda-Carreras","year":"2017","journal-title":"Bioinformatics"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s11548-021-02497-9","article-title":"High-resolution deep transferred ASPPU-Net for nuclei segmentation of histopathology images","volume":"16","author":"Chanchal","year":"2021","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"105267","DOI":"10.1016\/j.compbiomed.2022.105267","article-title":"DenseRes-Unet: Segmentation of overlapped\/clustered nuclei from multi organ histopathology images","volume":"143","author":"Kiran","year":"2022","journal-title":"Comput Biol Med"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Hoster","year":"2016","journal-title":"J Clin Oncol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.4161\/cbt.29691","article-title":"Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer","volume":"15","author":"Fang","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41419-018-0683-x","article-title":"HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration\/invasion via targeting miR-221\/222 in cervical cancer","volume":"9","author":"Fu","year":"2018","journal-title":"Cell Death Dis"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","article-title":"Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of breast cancer","volume":"118","author":"Jurikova","year":"2016","journal-title":"Acta Histochem"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.2147\/OTT.S150139","article-title":"PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer","volume":"10","author":"Li","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.22155","article-title":"Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer","volume":"120","author":"Rimkus","year":"2007","journal-title":"Int J Cancer"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/187152012800617678","article-title":"The role of Cdc25A in the regulation of cell proliferation and apoptosis","volume":"12","author":"Shen","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"38873","DOI":"10.1038\/srep38873","article-title":"Roles of human POLD1 and POLD3 in genome stability","volume":"6","author":"Tumini","year":"2016","journal-title":"Sci Rep"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4161\/cc.11.2.18995","article-title":"Fine-tuning of the intracellular canonical Notch signaling pathway","volume":"11","author":"Borggrefe","year":"2012","journal-title":"Cell Cycle"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2013-01-478834","article-title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","volume":"121","author":"Meissner","year":"2013","journal-title":"Blood"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anndiagpath.2019.05.004","article-title":"TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant","volume":"41","author":"Sakhdari","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/bloodadvances.2019001396","article-title":"Genomic profiles and clinical outcomes of de novo blastoid\/pleomorphic MCL are distinct from those of transformed MCL","volume":"4","author":"Jain","year":"2020","journal-title":"Blood Adv"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/S0046-8177(03)00412-X","article-title":"Cytogenetic findings in blastoid mantle cell lymphoma","volume":"34","author":"Khoury","year":"2003","journal-title":"Hum Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.21.01797","article-title":"Ibrutinib with rituximab in first-line treatment of older patients with mantle cell lymphoma","volume":"40","author":"Jain","year":"2022","journal-title":"J Clin Oncol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(21)00638-0","article-title":"Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (<\/=65\u00a0y) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial","volume":"23","author":"Wang","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:28Z","timestamp":1749416428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002068","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}